share_log

天茂集团(000627.SZ):尚未回购公司股份

Hubei Biocause Pharmaceutical (000627.SZ): has not yet repurchased the company's shares.

Gelonghui Finance ·  Dec 2, 2024 04:14

Gelonghui December 2nd| Hubei Biocause Pharmaceuticals (000627.SZ) announced that as of the close of November 29, 2024, the company's stock price was 4.19 yuan per share, exceeding the upper limit of the company's stock repurchase price. The company has repurchased a total of 0 shares of the company's stock through a designated securities account for stock repurchase using centralized bidding trading, accounting for 0.00% of the company's current total share capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment